Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.

MLA

Huang, Edmund, et al. “Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.” Clinical Journal of the American Society of Nephrology : CJASN, vol. 15, no. 1, Jan. 2020, pp. 109–16. EBSCOhost, https://doi.org/10.2215/CJN.04840419.

APA

Huang, E., Vo, A., Choi, J., Ammerman, N., Lim, K., Sethi, S., Kim, I., Kumar, S., Najjar, R., Peng, A., & Jordan, S. C. (2020). Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology : CJASN, 15(1), 109–116. https://doi.org/10.2215/CJN.04840419

Chicago

Huang, Edmund, Ashley Vo, Jua Choi, Noriko Ammerman, Kathlyn Lim, Supreet Sethi, Irene Kim, et al. 2020. “Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.” Clinical Journal of the American Society of Nephrology : CJASN 15 (1): 109–16. doi:10.2215/CJN.04840419.